Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - STOCK-BASED COMPENSATION
Stock-based Compensation NVO - Novo Nordisk A/S
2.15 B
LAST VALUE
43.75%
2 YEAR CAGR
39.01%
5 YEAR CAGR
18.05%
10 YEAR CAGR